Life Science Series: Know Your Options: Considering a “Virtual” Commercial Operation

Emerging biopharma companies have determined that a large pharma partner is not necessarily required to successfully launch a product in the US market. These companies are seeing an opportunity to retain control over the products they have worked so hard to develop by pursuing their own commercialization strategies in the form of a serviced-based, outsourced model. This “virtual” commercialization model minimizes internal systems and staffing while utilizing best-in-breed operational support at each stage of pre-launch commercial planning.

Since launching a product is one of the most critical times for emerging companies, and the makings of a successful launch start years before the product hits the market, executives must systematically develop plans to maximize commercial viability and ensure that logistics are coordinated and expertly managed. We will discuss a timeline that introduces the specific components of the virtual commercialization model as it relates to supply chain management, compliance programs, contract management, and government programs participation. Attendees will learn key insights and best practices from companies who successfully implemented this model.

Key Topics

• What are the key operational components of outsourced commercialization and back office support
• How to determine which activities are relevant to your business and the timeline for implementation
• What the compliance considerations are and the options to avoid unknown risks
• Why the US government market is important

Speakers

Register Here